Debanjana Chatterjee

Stock Analyst at Jones Trading

(3.71)
# 721
Out of 5,154 analysts
15
Total ratings
84.62%
Success rate
20.7%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Debanjana Chatterjee

Intellia Therapeutics
Mar 4, 2026
Upgrades: Buy
Price Target: $29
Current: $13.44
Upside: +115.77%
Armata Pharmaceuticals
Jan 5, 2026
Initiates: Buy
Price Target: $15
Current: $10.60
Upside: +41.51%
Spyre Therapeutics
Dec 1, 2025
Upgrades: Buy
Price Target: $64
Current: $40.15
Upside: +59.40%
Sionna Therapeutics
Sep 8, 2025
Initiates: Buy
Price Target: $46
Current: $35.93
Upside: +28.03%
Theravance Biopharma
Jun 17, 2025
Initiates: Buy
Price Target: $24
Current: $13.57
Upside: +76.86%
Sagimet Biosciences
Jun 6, 2025
Maintains: Buy
Price Target: $15$27
Current: $5.41
Upside: +399.08%
Tvardi Therapeutics
Apr 28, 2025
Initiates: Buy
Price Target: $39
Current: $3.93
Upside: +892.37%
KalVista Pharmaceuticals
Mar 26, 2025
Maintains: Buy
Price Target: $30
Current: $16.23
Upside: +84.84%
Contineum Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $23
Current: $13.88
Upside: +65.71%
Pharvaris
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $25.91
Upside: +77.54%